What Is Neurocrine Biosciences, Inc. (NBIX) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Neurocrine Biosciences, Inc.'s intrinsic value is estimated at $109.70, suggesting the stock is overvalued at its current price of $174.10. With 11 out of 13 models flagging downside (-37.0% average return), the market may be pricing in unsustainable growth. Model dispersion is worth noting: Markov DDM targets $211.98 (+21.8%), versus EPV at $15.52 (-91.1%). This +112.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About NBIX?
13 of 13 models are currently active for NBIX. Of these, 2 models suggest upside while 11 models suggest overvaluation. The Bayesian DCF estimates NBIX's intrinsic value at $102.19, implying -41.3% downside from the current price. See which stocks rank higher →
How Does NBIX Rank in Biological Products, (No Diagnostic Substances)?
Among 139 Biological Products, (No Diagnostic Substances) stocks, NBIX ranks #3 by Quality of Company score. CirclFi's QOC score of 10.0/10 evaluates 32 fundamental signals. A score of 10.0 places NBIX in the top tier.
See all Most Undervalued Biological Products, (No Diagnostic Substances) Stocks →
Neurocrine Biosciences, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is NBIX a Value Trap?
The Value Trap algorithm is not active for NBIX. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Neurocrine Biosciences, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi 32-factor quality framework, Neurocrine Biosciences, Inc.'s fundamental quality profile registers 10.0/10. This exceptional score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.
The gap between the most bullish and bearish model spans +112.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every NBIX valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across NBIX's 13 active models, average confidence is 43%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad